TELO Telomir Pharmaceuticals, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
TELO
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.1B
- Employees
- 5
- List Date
- 2024-02-09
- CIK
- 0001971532
- Next Earnings
- 2026-11-09
- Headquarters
- Miami, FL
- Homepage
- https://www.telomirpharma.com
Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small mole…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | -- | 19.41% | -14.93% | 2.24% |
| Feb | 81.40% | -4.08% | 4.10% | 27.14% |
| Mar | -43.09% | -21.41% | 4.84% | -19.89% |
| Apr | 21.25% | -6.93% | 6.06% | 6.79% |
| May | -11.36% | -22.51% | -7.14% | -13.67% |
| Jun | -14.11% | -40.48% | 2.40% | -17.40% |
| Jul | -15.06% | 47.24% | -9.00% | 7.73% |
| Aug | 51.23% | -25.00% | -9.68% | 5.52% |
| Sep | 29.44% | 15.83% | 9.09% | 18.12% |
| Oct | -31.19% | 12.23% | -14.66%* | -11.21% |
| Nov | -6.35% | -10.67% | -- | -8.51% |
| Dec | -3.06% | 3.10% | -- | 0.02% |
| Total | -1.02% | -48.91% | -28.35% | -26.09% |
* Only 3 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.10
SMA 50: $1.14
SMA 200: $1.23
Current: $1.00
EMA 12: $1.04
EMA 26: $1.09
MACD: -0.0476 | Signal: -0.0118
BEARISH
ADX (14): 30.82
TREND
+DI: 30.67
−DI: 17.05
Momentum Oscillators
RSI (14): 34.14
NEUTRAL
Stoch %K: 8.35
Stoch %D: 5.47
Williams %R: -83.96
Volume & Volatility
BB Upper: $1.24
BB Lower: $0.95
NEUTRAL
OBV: 182,168,605
Vol SMA 20: 129,062
Vol ROC: -34.44%
ATR: $0.07
True Range: $0.07
HV 20: 39.7%
HV 30: 46.1%
HV 60: 48.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is my comprehensive stock analysis report for TELO:
Executive Summary
Overall Assessment: BEARISH (confidence level 6/10)
Key Drivers: Technical indicators suggest a bearish trend, with MACD and RSI indicating potential selling pressure. News sentiment is neutral, but recent headlines may not be driving the market's response.
Primary Risks: High volatility, negative news sentiment, technical breakdown
Investment Thesis: TELO is likely to experience short-term price declines due to its high volatility and bearish technical signals. However, the stock's fundamental value and potential for long-term growth remain uncertain.
Recent News Sentiment Impact: Neutral news headlines have not had a significant impact on the stock's movement.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): BEARISH
- Medium-term (1-3 months): NEUTRAL
- Long-term (3-12 months): BULLISH
Support/Resistance Levels: Key price levels to monitor include SMA 20 ($1.26), EMA 12 ($1.24), and the lower Bollinger Band ($1.16).
Momentum Signals:
- RSI interpretation: NEUTRAL (41.40) - not oversold or overbought
- MACD signal: BEARISH (crossover below signal line)
- Bollinger Bands position: NEUTRAL (price near middle band)
Volume Analysis: Volume has been declining, indicating decreased institutional interest and potential selling pressure.
News & Sentiment Analysis
Recent Headlines Summary: Neutral news headlines have not had a significant impact on the stock's movement.
Sentiment Assessment: NEUTRAL
Catalyst Identification: No recent catalysts or earnings dates available. Potential long-term catalyst could be age-reversal drug developments.
Market Narrative: Technical signals suggest selling pressure, while neutral news headlines are not driving market movements.
Risk & Volatility Assessment
Beta Interpretation: HIGH RISK (beta 1.95)
Volatility Regime: CURRENT VOLATILITY > HISTORICAL VOLATILITY
Options Market Signals: No options data available for analysis.
Downside Protection: Support levels to monitor include SMA 20 ($1.26) and the lower Bollinger Band ($1.16).
Market Context & Positioning
Sector Performance: Relative strength vs sector/market not applicable (biotech/pharmaceuticals)
Institutional Activity: Volume has been declining, indicating decreased institutional interest.
Correlation Analysis: Correlation with SPY is low (0.21), suggesting this stock may be less correlated with the broader market.
Relative Valuation: Position within trading range unclear due to lack of historical price data.
Key Levels & Action Items
Critical Price Levels:
- SMA 20 ($1.26)
- EMA 12 ($1.24)
- Lower Bollinger Band ($1.16)
Breakout/Breakdown Levels: None identified
Time-Sensitive Catalysts: No recent catalysts or earnings dates available.
Risk Management: Monitor volume and technical indicators to adjust position sizing and stop-loss levels accordingly.
This comprehensive analysis provides a detailed review of TELO's technical, news, and risk metrics, highlighting the key drivers and primary risks for investors.
Generated
News
All TELO news →
TELO Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.6228
Alpha: -42.46%
Correlation: 0.3283
R-Squared: 10.8%
Stock Volatility: 63.0%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own TELO
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $17K | #6193 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TELO Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
TELO Insider Trading (Form 4)
Latest: 2026-07-27Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-07-27 | Edward Clouston MacPherson | Director | Grant (A) | +50,000 opt | — | EDGAR | |
| 2026-07-27 | Matthew Paul Del Giudice | Director | Grant (A) | +50,000 opt | — | EDGAR | |
| 2026-07-27 | Matthew Pratt Whalen | Director | Grant (A) | +50,000 opt | — | EDGAR | |
| 2026-05-22 | Matthew Paul Del Giudice | Director | Mixed | — | — | EDGAR | |
| 2026-05-22 | Matthew Pratt Whalen | Director | Mixed | — | — | EDGAR | |
| 2026-05-22 | Edward Clouston MacPherson | Director | Mixed | — | — | EDGAR | |
| 2026-05-22 | Erez Aminov | CEO and Chairman | Mixed | — | — | EDGAR | |
| 2026-04-24 | Erez Aminov | CEO and Chairman | Other (J) | +7,319,710 | $1.37 | $10.03M | EDGAR |
| 2025-05-30 | Erez Aminov | CEO and Chairman | Grant (A) | +2,400,000 RSU | — | EDGAR | |
| 2024-11-25 | Bay Shore Trust | 10%+ Owner | Gift (G) | −100,000 RSU | — | EDGAR | |
| 2024-09-04 | Michelle Yanez | Chief Financial Officer | Grant (A) | +200,000 opt | — | EDGAR | |
| 2024-08-29 | Erez Aminov | CEO & Chairman | Grant (A) | +1,960,170 opt | — | EDGAR | |
| 2024-08-29 | Edward Clouston MacPherson | Director | Grant (A) | +25,000 opt | — | EDGAR | |
| 2024-08-29 | Michael Allen Jerman | Director | Grant (A) | +25,000 opt | — | EDGAR | |
| 2024-08-29 | Matthew Paul Del Giudice | Director | Grant (A) | +25,000 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
TELO Insider Holdings
2 insiders · @ $1.00
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Erez Aminov | CEO and Chairman | 7,319,710 | $7.31M | $0 | 4 | 2026-05-22 |
| 2 | Bay Shore Trust | 10%+ Owner | 5,479,822 | $5.47M | $1.93M | 2 | 2024-11-25 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
TELO Board & Officers
As of SEC filings through Jul 27, 2026Directors 4
- Edward Clouston MacPherson · since Aug 8, 2024
- Erez Aminov · since Aug 8, 2024
- Matthew Paul Del Giudice · since Aug 8, 2024
- Matthew Pratt Whalen · since Aug 8, 2024
Officers 2
- Erez Aminov · CEO and Chairman · since Aug 8, 2024
- Andriy Mushak · Chief Financial Officer · since Jun 3, 2026
10% owners 1
- Mira Pharmaceuticals, Inc. (entity) · since Sep 29, 2025
Changes in the last 10 years (25)
| Jun 3, 2026 | The company announced the departure of Alan Weichselbaum as Chief Financial Officer in an SEC filing |
| Jun 3, 2026 | Andriy Mushak became Chief Financial Officer |
| Sep 29, 2025 | Mira Pharmaceuticals, Inc. became a 10% owner |
| May 15, 2025 | Alan Weichselbaum became Chief Financial Officer |
| Nov 18, 2024 | The company announced the departure of Michael Allen Jerman from the board in an SEC filing |
| Aug 8, 2024 | Matthew Pratt Whalen became a director |
| Aug 8, 2024 | Matthew Paul Del Giudice became a director |
| Aug 8, 2024 | Erez Aminov became a director |
| Aug 8, 2024 | Erez Aminov became CEO and Chairman |
| Aug 8, 2024 | Edward Clouston MacPherson became a director |
| Jun 18, 2024 | Michelle Yanez became Chief Financial Officer |
| Apr 10, 2024 | The company announced the departure of Christos Nicholoudis from the board in an SEC filing |
| Apr 10, 2024 | The company announced the departure of Christos Nicholoudis as General Counsel in an SEC filing |
| Feb 8, 2024 | Talhia Tuck became a director |
| Feb 8, 2024 | Nathen Fuentes became Chief Financial Officer |
| Feb 8, 2024 | Michael Allen Jerman became a director |
| Feb 8, 2024 | Hugh McColl III became a director |
| Feb 8, 2024 | Craig Eagle became a director |
| Feb 8, 2024 | Christos Nicholoudis became a director |
| Feb 8, 2024 | Christos Nicholoudis became General Counsel |
| Feb 8, 2024 | Christopher C Chapman JR became a director |
| Feb 8, 2024 | Christopher C Chapman JR became CEO & Chairman |
| Feb 8, 2024 | Brian Patrick McNulty became a 10% owner |
| Feb 8, 2024 | Bradley Kroenig became a director |
| Feb 8, 2024 | Bay Shore Trust became a 10% owner |
Not reported recently (9)
- Bay Shore Trust · Last reported as a 10% owner in an SEC filing dated Nov 25, 2024
- Michelle Yanez · Last reported as Chief Financial Officer in an SEC filing dated Sep 4, 2024
- Brian Patrick McNulty · Last reported as a 10% owner in an SEC filing dated Feb 15, 2024
- Talhia Tuck · Last reported as a director in an SEC filing dated Feb 8, 2024
- Nathen Fuentes · Last reported as Chief Financial Officer in an SEC filing dated Feb 8, 2024
- Craig Eagle · Last reported as a director in an SEC filing dated Feb 8, 2024
- Hugh McColl III · Last reported as a director in an SEC filing dated Feb 8, 2024
- Christopher C Chapman JR · Last reported as a director in an SEC filing dated Feb 8, 2024
- Bradley Kroenig · Last reported as a director in an SEC filing dated Feb 8, 2024
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
3 ETFs hold TELO
3 shown · $2.03M total exposure · 0.01% AUM-weighted avg weight
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.